Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Clinical prediction scores and early anticoagulation therapy for new-onset atrial fibrillation in critical illness: a post-hoc analysis

Fig. 2

Anticoagulation therapy and clinical outcomes in the group divided by CHA2DS2-VASc and HAS-BLED scores. a) For anticoagulation therapy and b) for mortality and the incidence of ischemic stroke and bleeding complocations. Stroke risk was determined using the CHA2DS2-VASc score (high risk of stroke [HS] ≥ 2; low risk of stroke [LS] < 2), and bleeding risk was determined using the HAS-BLED score (high risk of bleeding [HB] ≥ 3; low risk of bleeding [LB] < 3). We divided the patients into four groups based on both risks (HS/LB, HS/HB, LS/LB, and LS/HB). Only two patients were included in the LS/HB group

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us